Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Pollock, F. Abji, K. Liang, V. Chandran, F. Pellett, C. Virtanen, D. Gladman (2015)Gene expression differences between psoriasis patients with and without inflammatory arthritis.
The Journal of investigative dermatology, 135 2
J. Yao (1988)Biosynthesis of membrane cholesterol during peripheral nerve development, degeneration and regeneration
N. Schwab, J. Ulzheimer, R. Fox, T. Schneider-Hohendorf, T. Schneider-Hohendorf, B. Kieseier, C. Monoranu, S. Staugaitis, W. Welch, S. Jilek, R. Pasquier, W. Brück, K. Toyka, R. Ransohoff, H. Wiendl, H. Wiendl (2012)Fatal PML associated with efalizumab therapy
V. Chandran, S. Raychaudhuri (2010)Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis.
Journal of autoimmunity, 34 3
H. Niehues, I. Vlijmen-Willems, Judith Bergboer, Ferry Kersten, M. Narita, W. Hendriks, E. Bogaard, P. Zeeuwen, J. Schalkwijk (2016)Late cornified envelope (LCE) proteins: distinct expression patterns of LCE2 and LCE3 members suggest nonredundant roles in human epidermis and other epithelia
British Journal of Dermatology, 174
Kwan-Yeung Lee, K. Leung, N. Tang, M. Wong (2018)Discovering Genetic Factors for psoriasis through exhaustively searching for significant second order SNP-SNP interactions
Scientific Reports, 8
S. Shachar, O. Ziv, Sharon Avkin, S. Adar, J. Wittschieben, T. Reissner, S. Chaney, E. Friedberg, Zhigang Wang, T. Carell, N. Geacintov, Z. Livneh (2009)Two‐polymerase mechanisms dictate error‐free and error‐prone translesion DNA synthesis in mammals
The EMBO Journal, 28
E. Neumann, K. Khawaja, U. Müller-Ladner (2014)G protein-coupled receptors in rheumatology
Nature Reviews Rheumatology, 10
K. Papp, K. Gordon, D. Thaçi, A. Morita, M. Gooderham, P. Foley, I. Girgis, S. Kundu, Subhashish Banerjee (2018)Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
The New England Journal of Medicine, 379
Xueyuan Cao, Jin-Kui Yang, Li Wang (2020)A case–control study
M. Nelson, H. Tipney, Jeffery Painter, Judong Shen, P. Nicoletti, Yufeng Shen, A. Floratos, P. Sham, M. Li, Junwen Wang, L. Cardon, J. Whittaker, P. Sanseau, Hong Kong, Sar, ChinaNature Genetics Advance Online Publication a N a Ly S I S the Support of Human Genetic Evidence for Approved Drug Indications
M. Nogueira, L. Puig, T. Torres (2020)JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors
A. Elias, M. Goodman, M. Rohan (1993)Serum ICAM‐1 concentrations in patients with psoriasis treated with antithyroid thioureylenes
Clinical and Experimental Dermatology, 18
B. Jackson, C.M.L.J. Tilli, M. Hardman, A. Avilion, M. Macleod, G. Ashcroft, C. Byrne (2005)Late cornified envelope family in differentiating epithelia--response to calcium and ultraviolet irradiation.
The Journal of investigative dermatology, 124 5
Aidan MacNamara, N. Nakić, Ali Amin, Cong Guo, Karsten Sieber, M. Hurle, Alex Gutteridge (2020)Network and pathway expansion of genetic disease associations identifies successful drug targets
Scientific Reports, 10
N. Govind, A. Choudhury, B. Hodkinson, C. Ickinger, J. Frost, Annette Lee, P. Gregersen, R. Reynolds, S. Bridges, S. Hazelhurst, Michèle Ramsay, Michèle Ramsay, M. Tikly (2014)Immunochip Identifies Novel, and Replicates Known, Genetic Risk Loci for Rheumatoid Arthritis in Black South Africans
Molecular Medicine, 20
Hui Cheng, Yang Li, X. Zuo, Huayang Tang, Xian-fa Tang, Jinping Gao, Y. Sheng, X. Yin, F. Zhou, Chi Zhang, Gang Chen, Jun Zhu, Qian Pan, B. Liang, Xiao-dong Zheng, Pan Li, Yantao Ding, Fang Cheng, Jing Luo, R. Chang, G. Pan, Xing Fan, Zaixing Wang, A. Zhang, Jian-jun Liu, Sen Yang, Liangdan Sun, Xuejun Zhang (2014)Identification of a missense variant in LNPEP that confers psoriasis risk.
The Journal of investigative dermatology, 134 2
Julius Schwingen, M. Kaplan, F. Kurschus (2020)Review—Current Concepts in Inflammatory Skin Diseases Evolved by Transcriptome Analysis: In-Depth Analysis of Atopic Dermatitis and Psoriasis
International Journal of Molecular Sciences, 21
TingAn Wang, Yuzhou Qin, Hao Lai, WeiYuan Wei, Z. Li, Yang Yang, MingWei Huang, Jiansi Chen (2019)The prognostic value of ADRA1 subfamily genes in gastric carcinoma
Oncology Letters, 18
H. Qian, Mian Wang, Ying Wang, Wangqian Ying, Junhui Zhang, Y. Huan, Yan He, Yuan Liu, Guixiu Shi (2019)Role of Galphaq in pathogenesis of psoriasis, a new mechanism about the immune regulation in psoriasis
International Immunopharmacology, 68
E. Dowlatshahi, E. Voort, Lidia Arends, Tamar Nijsten (2013)Markers of systemic inflammation in psoriasis: a systematic review and meta‐analysis
British Journal of Dermatology, 169
M. Chimenti, A. D’Antonio, P. Conigliaro, S. Ferrigno, A. Vendola, M. Ferraioli, P. Triggianese, L. Costa, F. Caso, R. Perricone (2020)An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
Biologics : Targets & Therapy, 14
VanesaEsteban, MónicaRupérez, ElsaSánchez-López, JuanRodríguez-Vita, OscarLorenzo, HeidiDemaegdt, PatrickVanderheyden, JesúsEgido, MartaRuiz-Ortega (2005)Angiotensin IV Activates the Nuclear Transcription Factor-κB and Related Proinflammatory Genes in Vascular Smooth Muscle Cells
C. Fotiadou, E. Lazaridou, E. Sotiriou, D. Ioannides (2018)Targeting IL-23 in psoriasis: current perspectives
Psoriasis: Targets and Therapy, 8
D. d'Ambrosio, M. Freedman, J. Prinz (2016)Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases
Therapeutic Advances in Chronic Disease, 7
Genome-Wide Association Study Catalog
R. Ranza, S. Carneiro, A. Qureshi, G. Martins, J. Rodrigues, R. Romiti, T. Barros, J. Carneiro, A. Sampaio, Rachel Grynszpan, J. Markus, R. Pinto, C. Goldenstein-Schainberg (2015)Prevalence of Psoriatic Arthritis in a Large Cohort of Brazilian Patients with Psoriasis
The Journal of Rheumatology, 42
Qing Zhao, Yonghu Sun, X. Fu, Zhenzhen Wang, G. Yu, Z. Yue, Yaru Wang, Huimin Zhang, Chuan Wang, Hong Liu, Qing Yang, Furen Zhang (2019)Identification of a Single Nucleotide Polymorphism in NFKBIA with Different Effects on Psoriatic Arthritis and Cutaneous Psoriasis in China.
Acta dermato-venereologica, 99 1
P. Mease, D. Gladman, K. Papp, M. Khraishi, D. Thaçi, F. Behrens, R. Northington, J. Fuiman, E. Bananis, R. Boggs, D. Alvarez (2013)Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics.
Journal of the American Academy of Dermatology, 69 5
F. Batliwalla, Wentian Li, C. Ritchlin, Xiangli Xiao, M. Brenner, T. Laragione, T. Shao, R. Durham, Sunil Kemshetti, E. Schwarz, Rodney Coe, M. Kern, Emily Baechler, T. Behrens, P. Gregersen, P. Gulko (2005)Microarray Analyses of Peripheral Blood Cells Identifies Unique Gene Expression Signature in Psoriatic Arthritis
Molecular Medicine, 11
E. King, J. Davis, Jacob Degner (2019)Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval
PLoS Genetics, 15
Zichen Wang, Caroline Monteiro, Kathleen Jagodnik, Nicolas Fernandez, Gregory Gundersen, A. Rouillard, S. Jenkins, Axel Feldmann, Kevin Hu, Michael McDermott, Qiaonan Duan, N. Clark, Matthew Jones, Y. Kou, T. Goff, Holly Woodland, Fabio Amaral, G. Szeto, Oliver Fuchs, S. Rose, Shvetank Sharma, U. Schwartz, Xabier Bausela, Maciej Szymkiewicz, Vasileios Maroulis, A. Salykin, C. Barra, Candice Kruth, N. Bongio, Vaibhav Mathur, Radmila Todoric, Udi Rubin, A. Malatras, Carl Fulp, J. Galindo, R. Motiejūnaitė, Christoph Jüschke, Philip Dishuck, K. Lahl, Mohieddin Jafari, S. Aibar, A. Zaravinos, Linda Steenhuizen, Lindsey Allison, Pablo Gamallo, Fernando Segura, Tyler Devlin, V. Perez-Garcia, Avi Ma’ayan (2016)Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd
Nature Communications, 7
B. Gerber, M. Zanni, M. Uguccioni, M. Loetscher, C. Mackay, W. Pichler, N. Yawalkar, M. Baggiolini, B. Moser (1997)Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils
Current Biology, 7
J. Roszkiewicz, D. Michałek, A. Ryk, Z. Swacha, B. Szmyd, E. Smolewska (2020)The impact of single nucleotide polymorphisms in ADORA2A and ADORA3 genes on the early response to methotrexate and presence of therapy side effects in children with juvenile idiopathic arthritis: Results of a preliminary study
International Journal of Rheumatic Diseases, 23
Li Sun, Yuting Cao, N. He, Jian-Wen Han, R. Hai, S. Arlud, Baoyindeligeer He, W. Wu, Lizhong Li, X. Su, H. Cui, Wenchao Zhao, Buheqiqige Chao, Dandan Liu, Zhiqiang Sun, Ya-Lin Huang (2018)Association between LCE gene polymorphisms and psoriasis vulgaris among Mongolians from Inner Mongolia
Archives of Dermatological Research, 310
M. Dolcino, A. Ottria, A. Barbieri, Giuseppe Patuzzo, E. Tinazzi, Giuseppe Argentino, R. Beri, C. Lunardi, A. Puccetti (2015)Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis
PLoS ONE, 10
A. Fiorino, S. Baum, A. Czernik, R. Hall, T. Zeeli, A. Baniel, A. Sinha, K. Seiffert-Sinha, B. Kolatch, Z. Zhang, E. Sprecher (2019)570 Safety and efficacy of bertilimumab, a human anti-eotaxin-1 monoclonal antibody, in bullous pemphigoid in a phase 2a study
Journal of Investigative Dermatology
Judith Bergboer, G. Tjabringa, M. Kamsteeg, I. Vlijmen-Willems, D. Rodijk-Olthuis, P. Jansen, J. Thuret, M. Narita, A. Ishida‐Yamamoto, P. Zeeuwen, J. Schalkwijk (2011)Psoriasis risk genes of the late cornified envelope-3 group are distinctly expressed compared with genes of other LCE groups.
The American journal of pathology, 178 4
E. Guttman‐Yassky, Y. Vugmeyster, M. Lowes, Francesca Chamian, T. Kikuchi, M. Kagen, P. Gilleaudeau, Edmund Lee, B. Hunte, K. Howell, W. Dummer, S. Bodary, J. Krueger (2008)Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness.
The Journal of investigative dermatology, 128 5
Tara Rachakonda, C. Schupp, A. Armstrong (2014)Psoriasis prevalence among adults in the United States.
Journal of the American Academy of Dermatology, 70 3
F. Capon (2017)The Genetic Basis of Psoriasis
International Journal of Molecular Sciences, 18
J. Doles, T. Oliver, E. Cameron, Gerald Hsu, T. Jacks, G. Walker, M. Hemann (2010)Suppression of Rev3, the catalytic subunit of Polζ, sensitizes drug-resistant lung tumors to chemotherapy
Proceedings of the National Academy of Sciences, 107
G. Elia (2018)MIG in psoriatic arthritis.
La Clinica terapeutica, 169 6
S. Forman, D. Pariser, Y. Poulin, M. Vincent, S. Gilbert, E. Kieras, R. Qiu, Dahong Yu, Jocelyne Papacharalambous, C. Tehlirian, E. Peeva (2020)TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-blind, Placebo-controlled Trial.
The Journal of investigative dermatology
R. Prieto-Pérez, M. Llamas‐Velasco, T. Cabaleiro, G. Solano-López, B. Márquez, M. Román, D. Ochoa, M. Talegón, E. Daudén, F. Abad‐Santos (2017)Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis.
Pharmacogenomics, 18 2
Hai Fang, H. Wolf, B. Knezevic, K. Burnham, Julie Osgood, Anna Sanniti, Alicia Lara, S. Kasela, Stephane Cesco, J. Wegner, L. Handunnetthi, F. McCann, Liye Chen, T. Sekine, P. Brennan, B. Marsden, David Damerell, C. O'Callaghan, C. Bountra, P. Bowness, Y. Sundström, L. Milani, L. Berg, Hinrich Göhlmann, P. Peeters, B. Fairfax, M. Sundström, J. Knight (2019)A genetics-led approach defines the drug target landscape of 30 immune-related traits
Nature Genetics, 51
R. Parisi, D. Symmons, C. Griffiths, D. Ashcroft (2013)Global epidemiology of psoriasis: a systematic review of incidence and prevalence.
The Journal of investigative dermatology, 133 2
G. Gan, J. Wittschieben, Birgitte Wittschieben, R. Wood (2008)DNA polymerase zeta (pol ζ) in higher eukaryotes
Cell Research, 18
Xing Guo, J. Engel, Junyu Xiao, V. Tagliabracci, Xiaorong Wang, Lan Huang, J. Dixon (2011)UBLCP1 is a 26S proteasome phosphatase that regulates nuclear proteasome activity
Proceedings of the National Academy of Sciences, 108
Yung-Ting Chang, Chi-Yi Hsu, C. Chou, Ming-Wei Lin, Y. Shiao, Chang-Youh Tsai, Chia-Wen Yu, Jen-Jen Shiue, Yu-Fen Lee, Cheng‐Hung Huang, Chih-Chiang Chen, Ding-Dar Lee, Wen‐Jen Wang, Han-Nan Liu, S. Tsai (2007)The genetic polymorphisms of POU5F1 gene are associated with psoriasis vulgaris in Chinese.
Journal of dermatological science, 46 2
G. Caldarola, A. Sgambato, C. Fanali, G. Moretta, M. Farina, D. Lucchetti, K. Peris, C. Simone (2016)HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients
Pharmacogenetics and Genomics, 26
C. Conrad, J. Domizio, A. Mylonas, C. Belkhodja, O. Demaria, A. Navarini, Anne-Karine Lapointe, L. French, M. Vernez, M. Gilliet (2018)TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis
Nature Communications, 9
D. Gladman, C. Antoni, P. Mease, D. Clegg, P. Nash (2005)Psoriatic arthritis: epidemiology, clinical features, course, and outcome
Annals of the Rheumatic Diseases, 64
H. Alshobaili, Muhammad Shahzad, Abdullah Al-Marshood, Alsayed Khalil, A. Settin, Issam Barrimah (2010)Genetic background of psoriasis.
International journal of health sciences, 4 1
H. Niehues, L. Tsoi, Danique Krieken, P. Jansen, M. Oortveld, D. Rodijk-Olthuis, I. Vlijmen, W. Hendriks, Richard Helder, J. Bouwstra, E. Bogaard, P. Stuart, R. Nair, James Elder, P. Zeeuwen, J. Schalkwijk (2017)Psoriasis-Associated Late Cornified Envelope (LCE) Proteins Have Antibacterial Activity.
The Journal of investigative dermatology, 137 11
Ling-juan Zhang (2019)Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis
Frontiers in Immunology, 10
Xing Fan, Hongyan Wang, Liangdan Sun, Xiao-dong Zheng, X. Yin, X. Zuo, Qian Peng, K. Standish, Hui Cheng, Yaohua Zhang, Zaixing Wang, F. Xiao, Sen Yang, Xuejun Zhang, N. Schork (2019)Fine mapping and subphenotyping implicates ADRA1B gene variants in psoriasis susceptibility in a Chinese population.
Epigenomics, 11 4
P. Szodoray, P. Alex, C. Chappell-Woodward, T. Madland, N. Knowlton, I. Dozmorov, M. Zeher, J. Jarvis, B. Nakken, J. Brun, M. Centola (2007)Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system.
Rheumatology, 46 3
Chen Cao, J. Moult (2014)GWAS and drug targets
BMC Genomics, 15
Yihong Yao, L. Richman, C. Morehouse, M. Reyes, B. Higgs, A. Boutrin, B. White, A. Coyle, J. Krueger, P. Kiener, B. Jallal (2008)Type I Interferon: Potential Therapeutic Target for Psoriasis?
PLoS ONE, 3
Dominik Schenten, S. Kracker, G. Esposito, S. Franco, U. Klein, Michael Murphy, F. Alt, K. Rajewsky (2009)Polζ ablation in B cells impairs the germinal center reaction, class switch recombination, DNA break repair, and genome stability
The Journal of Experimental Medicine, 206
A. Bressan, B. Picciani, L. Azulay-Abulafia, A. Fausto-Silva, P. Almeida, K. Cunha, E. Dias, Sueli Carneiro (2018)Evaluation of ICAM‐1 expression and vascular changes in the skin of patients with plaque, pustular, and erythrodermic psoriasis
International Journal of Dermatology, 57
Prapon Donnell, J. Hughes, Elisabeth Higgins, Richard Groves, A. Pembroke (1995)A fatal case of capillary leak syndrome in erythrodermic psoriasis
British Journal of Dermatology, 132
Sabine Lange, Sarita Bhetawal, Shelley Reh, K. Powell, D. Kusewitt, R. Wood (2018)DNA polymerase ζ deficiency causes impaired wound healing and stress-induced skin pigmentation
Life Science Alliance, 1
K. Kofoed, L. Skov, C. Zachariae (2015)New drugs and treatment targets in psoriasis.
Acta dermato-venereologica, 95 2
H. Duncan, D. OberG, W. Eyler (1965)PSORIATIC ARTHRITIS.
Henry Ford Hospital medical bulletin, 13
A. Rouillard, Gregory Gundersen, Nicolas Fernandez, Zichen Wang, Caroline Monteiro, Michael McDermott, Avi Ma’ayan (2016)The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins
Database: The Journal of Biological Databases and Curation, 2016
V. Esteban, M. Rupérez, E. Sanchez-Lopez, J. Rodríguez-Vita, Ó. Lorenzo, H. Demaegdt, P. Vanderheyden, J. Egido, M. Ruíz-Ortega (2005)Angiotensin IV Activates the Nuclear Transcription Factor-&kgr;B and Related Proinflammatory Genes in Vascular Smooth Muscle Cells
Circulation Research, 96
(2015)Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
J. Sadeh, D. Rudikoff, M. Gordon, Jeffery Bowden, B. Goldman, M. Lebwohl (1997)Pustular and erythrodermic psoriasis complicated by acute respiratory distress syndrome.
Archives of dermatology, 133 6
Catherine Ni, M. ChiuClinical, Cosmetic and Investigational Dermatology Dovepress Psoriasis and Comorbidities: Links and Risks
C. Banfield, M. Scaramozza, Weidong Zhang, E. Kieras, K. Page, A. Fensome, M. Vincent, M. Dowty, K. Goteti, P. Winkle, E. Peeva (2018)The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF‐06700841) in Healthy Subjects and Patients With Plaque Psoriasis
The Journal of Clinical Pharmacology, 58
Petar Pajic, Yen-Lung Lin, Duo Xu, O. Gokcumen (2016)The psoriasis-associated deletion of late cornified envelope genes LCE3B and LCE3C has been maintained under balancing selection since Human Denisovan divergence
BMC Evolutionary Biology, 16
K. Miyoshi, M. Takaishi, K. Nakajima, Mitsunori Ikeda, T. Kanda, M. Tarutani, T. Iiyama, N. Asao, J. DiGiovanni, S. Sano (2011)Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor.
The Journal of investigative dermatology, 131 1
Lin-kun Zhong, X. Gan, Xing-yan Deng, F. Shen, Jian-hua Feng, Wen-song Cai, Qiong-yao Liu, Jian-hang Miao, B. Zheng, Bo Xu (2020)Potential five-mRNA signature model for the prediction of prognosis in patients with papillary thyroid carcinoma
Oncology Letters, 20
Background:Despite numerous genome-wide association studies conducted in psoriasis and psoriatic arthritis, only a small fraction of the identified genes has been therapeutically targeted.Objective:We sought to identify and analyze potential therapeutic targets for psoriasis and psoriatic arthritis (PsA) using the priority index (Pi), a genetics-dependent drug target prioritization approach.Methods:Significant genetic variants from GWAS for psoriasis, PsA, and combined psoriatic disease were annotated and run through the Pi pipeline. Potential drug targets were identified based on genomic predictors, annotation predictors, pathway enrichment, and pathway crosstalk.Results:Several gene targets were identified for psoriasis and PsA that demonstrated biological associations to their respective diseases. Some are currently being explored as potential therapeutic targets (i.e. ICAM1, NF-kB, REV3 L, ADRA1B for psoriasis; CCL11 for PsA); others have not yet been investigated (i.e. LNPEP, LCE3 for psoriasis; UBLCP1 for PsA). Additionally, many nodal points of potential intervention were identified as promising therapeutic targets. Of these, some are currently being studied such as TYK2 for psoriasis, and others have yet to be explored (i.e. PPP2CA, YAP1, PI3 K, AKT, FOXO1, RELA, CSF2, IFNGR1, IFNGR2 for psoriasis; GNAQ, PLCB1, GNAI2 for PsA).Conclusion:Through Pi, we identified data-driven candidate therapeutic gene targets and pathways for psoriasis and PsA. Given the sparse PsA specific genetic studies and PsA specific drug targets, this analysis could prove to be particularly valuable in the pipeline for novel psoriatic therapies.
Journal of Psoriasis and Psoriatic Arthritis – SAGE
Published: Oct 1, 2021
Access the full text.
Sign up today, get DeepDyve free for 14 days.